Texas Ruling Having Ripple Effect Across Biotech
The US equities markets were mostly neutral today, with the major indexes and sectors generally trading slightly higher. However, both healthcare and its biotech subsector were down at least 1% today, partly as a result of expectations of significantly more legislative pushes against the Affordable Care Act in the wake of a Texas judge ruling […]
Read Article